
BGLC Technical Analysis Summary (NASDAQ)
Analyze BGLC on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerBGLC Technical Analysis Summary (NASDAQ)
BioNexus Gene Lab Corp. (NASDAQ: BGLC) stock currently shows a neutral trend on the NASDAQ, supported by momentum and balanced buying pressure.
Technical conditions suggest BioNexus Gene Lab Corp. on the NASDAQ is awaiting a decisive move. Technical conditions suggest BioNexus Gene Lab Corp. is consolidating, awaiting a decisive move.
RSI (14): 36.08
Stochastic %K: 34.88
Williams %R: -86.11
Rate of Change (ROC): -7.14
Takeaway:BioNexus Gene Lab Corp. shows strong bearish momentum, signaling downside pressure.
MACD: -0.04
ADX: 16.28
ATR (14): 0.10
CCI (14): -224.97
Takeaway:BioNexus Gene Lab Corp. shows a neutral trend, with weak conviction and limited volatility.
Takeaway:BioNexus Gene Lab Corp. trades near the lower band, signaling oversold conditions and potential rebound.
Takeaway:BioNexus Gene Lab Corp. trades below the trend line, showing weaker momentum inside the channel.
Overall Takeaway:BGLC shows mixed signals in money flow analysis.
Bullish Signals
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
MACD below signal line → short-term caution on momentum.
RVI below 50 → vigor tilted toward sellers.
Overall Recommendation:Technical indicators for BioNexus Gene Lab Corp. are mixed, suggesting a Hold or wait-and-see approach.